Skip to main content

noComment
| |

Scientists at London’s King College say they’ve carried out encouraging tests on a new treatment that promises to shrink breast cancer tumours and help prolong the lives of women with aggressive hereditary cancers.

The drug “olaparib” is in the early stages of development and will not be available for several years to come, but by targetting the faulty genes which cause cancer, it may one day help women with a high level of hereditary risk.

More about: ,

Copyright © 2012 euronews

| |

Login

Please enter your login details

Join the euronews community

By joining euronews’ community , you can participate to U talk and I talk and subscribe to our newsletters.
Please note: All fields are required